AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2020, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2020-01-23
DOI
10.1155/2020/7262479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current and Emerging Targets in Immunotherapy for Osteosarcoma
- (2019) Shinji Miwa et al. Journal of Oncology
- Adiponectin as Link Factor between Adipose Tissue and Cancer
- (2019) Erika Di Zazzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells
- (2019) Amin A. Ramzan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Osteosarcoma, Chondrosarcoma, and Chordoma
- (2018) Jeremy S. Whelan et al. JOURNAL OF CLINICAL ONCOLOGY
- The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes
- (2018) Yaeni Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines
- (2018) E. Nigro et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Serum adiponectin and insulin secretion: A direct or inverse association?
- (2018) Akinobu Nakamura et al. Journal of Diabetes Investigation
- Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
- (2018) Amanda J. Saraf et al. Frontiers in Oncology
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis
- (2018) Miho Akimoto et al. Cell Death & Disease
- Progress in the chemotherapeutic treatment of osteosarcoma (Review)
- (2018) Ya Zhang et al. Oncology Letters
- Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells
- (2018) Hong-Wei Zhang et al. Scientific Reports
- Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression
- (2018) Sarah Nicolas et al. Translational Psychiatry
- Current and future therapeutic approaches for osteosarcoma
- (2017) Douglas J. Harrison et al. Expert Review of Anticancer Therapy
- Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis
- (2017) Yuya Fujishima et al. FASEB JOURNAL
- Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling
- (2017) Simon J. Cook et al. FEBS Journal
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
- (2017) D. Matthew Gianferante et al. Nature Reviews Endocrinology
- AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia
- (2017) Arwa Fairaq et al. PHARMACOLOGICAL RESEARCH
- Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells
- (2017) Michela Illiano et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
- (2017) Fanuel Messaggio et al. Oncotarget
- Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome
- (2017) Gema Frühbeck et al. Scientific Reports
- The Activity of Adiponectin in Bone
- (2016) Dorit Naot et al. CALCIFIED TISSUE INTERNATIONAL
- Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
- (2016) Jennifer H. Stern et al. Cell Metabolism
- Inhibition of ERK1/2 Signaling Pathway is Involved in Melatonin's Antiproliferative Effect on Human MG-63 Osteosarcoma Cells
- (2016) Lifeng Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?
- (2016) Luigi Sapio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adiponectin, the past two decades
- (2016) Zhao V. Wang et al. Journal of Molecular Cell Biology
- AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings
- (2015) Yanqing Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
- (2015) T. E. Witzig et al. BLOOD
- An update on chemotherapy for osteosarcoma
- (2015) Stefano Ferrari et al. EXPERT OPINION ON PHARMACOTHERAPY
- S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells
- (2015) Concetta Paola Ilisso et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Crystal structures of the human adiponectin receptors
- (2015) Hiroaki Tanabe et al. NATURE
- The dual role of ERK signaling in the apoptosis of neurons
- (2014) Qiang Li Frontiers in Bioscience-Landmark
- Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma
- (2014) Carola Porcile et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Differential effects of adiponectin in osteoblast-like cells
- (2014) Elda L. Pacheco-Pantoja et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection
- (2014) Emmanuel Datan et al. VIROLOGY
- Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase
- (2013) Alessandra Rossi et al. APOPTOSIS
- Regulation of adiponectin multimerization, signaling and function
- (2013) Meilian Liu et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
- (2013) Y. Pignochino et al. CLINICAL CANCER RESEARCH
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- The Role of Adiponectin in Cancer: A Review of Current Evidence
- (2012) Maria Dalamaga et al. ENDOCRINE REVIEWS
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- mTOR-Dependent Cell Survival Mechanisms
- (2012) C.-M. Hung et al. Cold Spring Harbor Perspectives in Biology
- Adiponectin Induces Vascular Smooth Muscle Cell Differentiation via Repression of Mammalian Target of Rapamycin Complex 1 and FoxO4
- (2011) Min Ding et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Influence of Adipokines and Ghrelin on Bone Mineral Density and Fracture Risk: A Systematic Review and Meta-Analysis
- (2011) Emmanuel Biver et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effects of adiponectin and leptin on changes in bone mineral density
- (2011) K. E. Barbour et al. OSTEOPOROSIS INTERNATIONAL
- Regulation of survivin by PI3K/Akt/p70S6K1 pathway
- (2010) Peng Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adiponectin and bone mass density: The InCHIANTI study
- (2010) Nicola Napoli et al. BONE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now